BIM
GNMK

Bogle Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bogle Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,400
Closed -$342K – 141
2020
Q4 		$342K Buy
23,400
+1,500
+7% +$19.9K 0.54% 99
2020
Q3 		$311K Sell
21,900
-26,227
-54% -$401K 0.09% 201
2020
Q2 		$708K Buy
+48,127
New +$489K 0.12% 184
2016
Q4 		– Sell
-146,893
Closed -$1.73M – 435
2016
Q3 		$1.73M Buy
+146,893
New +$1.42M 0.12% 175
2016
Q2 		– Sell
-136,821
Closed -$721K – 504
2016
Q1 		$721K Buy
136,821
+122,213
+837% +$680K 0.05% 299
2015
Q4 		$113K Buy
+14,608
New +$112K 0.01% 358

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bogle Investment Management's GNMK Position: Q1 2021 in Review

Bogle Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 23,400 shares — an estimated $342K sold.

Bogle Investment Management first reported a position in GNMK in Q4 2015 and held it in 6 quarters. The position peaked at $1.73M in Q3 2016. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Bogle Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Bogle Investment Management sold 23,400 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $342K.
  • Bogle Investment Management first reported a position in GenMark Diagnostics, Inc in Q4 2015 and held it in 6 quarters.
  • Bogle Investment Management's GenMark Diagnostics, Inc position peaked at $1.73M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Bogle Investment Management's 13F filing for Q1 2021.